India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to stay on top
--------------------------------------------------------------------
Source: CNBC
Published: 2026-03-23 21:10 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Economy & Finance, Financial Markets, India, Drugs, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
The first wave of generic versions of Novo Nordisk's GLP-1 weight-loss drugs launched in India over the weekend, with at least five domestic drugmakers undercutting the original price by up to 80%. It comes as the Danish drugmaker's patent expired on Friday, with the company fighting to maintain its lead in the lucrative market.
--------------------------------------------------------------------